BLUE – bluebird bio, inc. (US:NASDAQ)
Stock Stats
News
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
bluebird bio Adjourns Meeting of Stockholders and Announces Third Quarter Results Call
bluebird bio to Present Additional Long-Term Follow-up Data from Gene Therapy Programs in Sickle Cell Disease and Beta-Thalassemia at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
bluebird bio, Inc. (NASDAQ: BLUE) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Form SC 13G/A bluebird bio, Inc. Filed by: GOLDMAN SACHS GROUP INC
Form 4 bluebird bio, Inc. For: Nov 06 Filed by: Tita-Reid Najoh
Form 4 bluebird bio, Inc. For: Nov 06 Filed by: Paulson Richard A.
Form 4 bluebird bio, Inc. For: Nov 06 Filed by: Agwunobi John O
Form 4 bluebird bio, Inc. For: Nov 06 Filed by: Jones-Burton Charlotte
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.